Henry Schein, Inc. (NASDAQ:HSIC) Stock Position Decreased by Swiss National Bank

Swiss National Bank trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 3.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 408,300 shares of the company's stock after selling 13,100 shares during the period. Swiss National Bank owned approximately 0.31% of Henry Schein worth $30,912,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Raymond James Financial Services Advisors Inc. raised its stake in Henry Schein by 15.8% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 7,057 shares of the company's stock valued at $524,000 after purchasing an additional 965 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Henry Schein by 8.1% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,528 shares of the company's stock valued at $1,747,000 after buying an additional 1,773 shares during the period. Mackenzie Financial Corp increased its holdings in shares of Henry Schein by 0.9% during the third quarter. Mackenzie Financial Corp now owns 62,672 shares of the company's stock valued at $4,577,000 after acquiring an additional 562 shares in the last quarter. Strs Ohio raised its holdings in Henry Schein by 13.6% during the third quarter. Strs Ohio now owns 30,886 shares of the company's stock worth $2,293,000 after buying an additional 3,687 shares during the last quarter. Finally, IFM Investors Pty Ltd lifted its position in Henry Schein by 11.8% in the 3rd quarter. IFM Investors Pty Ltd now owns 27,540 shares of the company's stock valued at $2,045,000 after acquiring an additional 2,914 shares in the last quarter. Institutional investors own 96.62% of the company's stock.

Insider Transactions at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now owns 73,108 shares of the company's stock, valued at approximately $5,430,462.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares in the company, valued at $5,430,462.24. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC traded up $0.68 during midday trading on Thursday, reaching $73.44. The company's stock had a trading volume of 1,322,592 shares, compared to its average volume of 1,110,600. The firm has a market capitalization of $9.44 billion, a PE ratio of 23.31, a P/E/G ratio of 1.68 and a beta of 0.87. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $82.63. The stock has a fifty day moving average of $72.95 and a 200 day moving average of $72.35. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.09. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The company's revenue was up 3.7% compared to the same quarter last year. During the same period last year, the firm posted $1.21 earnings per share. On average, equities analysts expect that Henry Schein, Inc. will post 5.07 EPS for the current fiscal year.

Analyst Ratings Changes

HSIC has been the topic of several research reports. Evercore ISI lifted their price objective on shares of Henry Schein from $79.00 to $83.00 and gave the stock an "in-line" rating in a research report on Wednesday, February 28th. SVB Leerink started coverage on shares of Henry Schein in a research report on Monday, February 26th. They set a "market perform" rating and a $78.00 price target for the company. Barrington Research raised their target price on shares of Henry Schein from $90.00 to $92.00 and gave the company an "outperform" rating in a research note on Wednesday. Leerink Partnrs reaffirmed a "market perform" rating on shares of Henry Schein in a research note on Monday, February 26th. Finally, Jefferies Financial Group lifted their target price on shares of Henry Schein from $74.00 to $81.00 and gave the stock a "hold" rating in a research report on Wednesday, March 6th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, Henry Schein has an average rating of "Hold" and an average target price of $81.73.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.